Blood Separation Tubes Combine Serum Analysis with Plasma Analysis
By LabMedica International staff writers Posted on 09 Jul 2018 |

Image: The Vacuette Serum Fast Tubes, which offer a coagulation time of only five minutes (Photo courtesy of Greiner Bio-One).
A new line of blood separation tubes combines the quality of serum analysis with the speed of plasma analysis.
Greiner Bio-One (Kremsmünster, Austria) has released the Vacuette Serum Fast Tube, which with coagulation time of only five minutes enables serum to be analyzed as quickly as plasma.
The inside of the Vacuette tube wall is spray-coated with a Blood Clotting Activator (BCA)-thrombin additive mixture, which accelerates the coagulation process. With the Vacuette Serum Fast Tube, the total processing time is just 10 minutes (coagulation + centrifugation), compared to 40 minutes with conventional serum tubes, enabling easy and effective improvement of the turnaround time (TAT).
The tube also contains a gel that forms a stable barrier between the serum and the cellular components of the whole blood after centrifugation (five minutes at 3000 x g or 10 minutes at 1800 x g at 20 degrees Celsius).
To protect against contamination Vacuette Serum Fast Tubes are made of shatterproof PET (polyethylene terephthalate). They incorporate proven vacuum technology and have an easy-to-open safety cap. This promotes maintenance of hygienic working procedures without the risk of splatters, which can occur with standard rubber stoppers.
“Owing to the fast turnaround time, plasma tubes continue to be used for many analyses. However, determination of certain parameters on the basis of plasma is not appropriate for some tests,” said Dietmar Leichtfried, team leader research & development / preanalytics at Greiner Bio-One. "In some cases, incorrect values may result from the presence of anticoagulants or fibrinogen in the plasma tube. The use of serum is therefore indispensable in many cases."
Greiner Bio-One (Kremsmünster, Austria) has released the Vacuette Serum Fast Tube, which with coagulation time of only five minutes enables serum to be analyzed as quickly as plasma.
The inside of the Vacuette tube wall is spray-coated with a Blood Clotting Activator (BCA)-thrombin additive mixture, which accelerates the coagulation process. With the Vacuette Serum Fast Tube, the total processing time is just 10 minutes (coagulation + centrifugation), compared to 40 minutes with conventional serum tubes, enabling easy and effective improvement of the turnaround time (TAT).
The tube also contains a gel that forms a stable barrier between the serum and the cellular components of the whole blood after centrifugation (five minutes at 3000 x g or 10 minutes at 1800 x g at 20 degrees Celsius).
To protect against contamination Vacuette Serum Fast Tubes are made of shatterproof PET (polyethylene terephthalate). They incorporate proven vacuum technology and have an easy-to-open safety cap. This promotes maintenance of hygienic working procedures without the risk of splatters, which can occur with standard rubber stoppers.
“Owing to the fast turnaround time, plasma tubes continue to be used for many analyses. However, determination of certain parameters on the basis of plasma is not appropriate for some tests,” said Dietmar Leichtfried, team leader research & development / preanalytics at Greiner Bio-One. "In some cases, incorrect values may result from the presence of anticoagulants or fibrinogen in the plasma tube. The use of serum is therefore indispensable in many cases."
Latest Technology News
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
- Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management
- First AI-Powered Blood Test Identifies Patients in Earliest Stage of Breast Cancer
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Revolutionary Blood Test Detects 30 Different Types of Cancers with 98% Accuracy
With cancer expected to become the leading cause of global mortality by 2030, early detection remains the most effective strategy to reduce death rates. Current screening methods only cover five types... Read more
Simple Blood Test Better Predicts Heart Disease Risk
Cardiovascular diseases (CVDs) are the primary cause of death worldwide. A large proportion of these cases could be prevented by addressing lifestyle and environmental factors such as smoking, poor diet,... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more